- Featured Product
- KD/KO Validated
PARK2/Parkin Monoklonaler Antikörper
PARK2/Parkin Monoklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG2b
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2H5A7
Kat-Nr. : 66674-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66674-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA PARK2/Parkin und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Maus / IgG2b |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | PARK2/Parkin fusion protein Ag5179 |
Vollständiger Name | Parkinson disease (autosomal recessive, juvenile) 2, parkin |
Berechnetes Molekulargewicht | 52 kDa |
Beobachtetes Molekulargewicht | 42-52 kDa |
GenBank-Zugangsnummer | BC022014 |
Gene symbol | Parkin |
Gene ID (NCBI) | 5071 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Parkin, a RING-type E3 ubiquitin-protein ligase, is involved in the ubiquitination pathway and contributes to protection from neurotoxicity induced by unfolded protein stresses. Its ubiquitin-protein ligase activity promotes the degradation of a viariety of proteins including itself. Mutations in Parkin are implicated in the pathogenesis of autosomal recessive familial Parkinson's disease. It has 8 isoforms produced by alternative splicing.